Expertise in
5
conditions

Dr. Mark E. Mailliard

Gastroenterology
UNMC Physicians
988102 Nebraska Medical Ctr, 
Omaha, NE 
Expertise in
5
conditions
UNMC Physicians
988102 Nebraska Medical Ctr, 
Omaha, NE 

Overview

Mark Mailliard is a Gastroenterologist practicing medicine in Omaha, Nebraska.

Dr. Mailliard is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Autoimmune Hepatitis, Endoscopy, and Colonoscopy.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 4 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in NE

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

UNMC Physicians
988102 Nebraska Medical Ctr, Omaha, NE 68198

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Enrollment Status: Completed
Publish Date: February 28, 2024
A Phase IV, Single Arm, Open-Label Study to Determine the Efficacy and Safety of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Naive Alcoholic Subjects With Chronic Genotype 1 Hepatitis C Infection
A Phase IV, Single Arm, Open-Label Study to Determine the Efficacy and Safety of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Naive Alcoholic Subjects With Chronic Genotype 1 Hepatitis C Infection
Enrollment Status: Completed
Publish Date: December 29, 2023
Intervention Type: Drug
Study Drug: Harvoni
Study Phase: Phase 4
Comparison of Standard Therapy,Peginterferon Alpha-2a + Ribavirin for 48 Weeks VS Peginterferon Alph-2a + Ribavirin + Betaine for 12 Weeks Followed by 36 Weeks Standard Therapy in Untreated Adults With Chronic Hepatitis C Genotype 1
Comparison of Standard Therapy,Peginterferon Alpha-2a + Ribavirin for 48 Weeks VS Peginterferon Alph-2a + Ribavirin + Betaine for 12 Weeks Followed by 36 Weeks Standard Therapy in Untreated Adults With Chronic Hepatitis C Genotype 1
Enrollment Status: Withdrawn
Publish Date: August 15, 2023
Intervention Type: Drug
Study Phase: Not Applicable
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Enrollment Status: Completed
Publish Date: December 06, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

4 Total Publications

Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
Journal: Digestive diseases and sciences
Published: March 30, 2023

Frequently Asked Questions about Dr. Mark E. Mailliard

How do I make an appointment with Dr. Mark E. Mailliard?

You can book an appointment with Dr. Mark E. Mailliard by calling their office at 402-559-4015. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark E. Mailliard a top-rated expert for Hepatitis C?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark E. Mailliard is classified as an Distinguished expert for Hepatitis C, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark E. Mailliard specialize in?

While Dr. Mark E. Mailliard is a Gastroenterology, they have specific expertise in Hepatitis C, Hepatitis, and Endoscopy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Mark E. Mailliard participate in research or clinical trials?

Yes. Dr. Mark E. Mailliard has published 4 articles and abstracts on conditions like Hepatitis C. You can view a list of Dr. Mark E. Mailliard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark E. Mailliard accept my insurance?

Dr. Mark E. Mailliard accepts most major insurance plans, including Humana. We recommend calling the office directly at 402-559-4015 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mailliard's expertise for a condition
ConditionClose
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile